Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Neu

Showing results (241-250 of 505) with videos related to

Pageof 51
Sort By:
Chemotherapy|January 1, 1986
In vitro activity of A-16686, a new glycopeptideH C Neu, N M Neu
Chest|November 1, 1993
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infectionsH C Neu, T W Chick
The Journal of Infectious Diseases|August 1, 1976
Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosisM F Parry, H C Neu
Antimicrobial Agents and Chemotherapy|August 1, 1992
In vitro activity of MC-352, a new 16-membered macrolideN X Chin, H C Neu
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
In vitro antimicrobial activity of the new antibiotic vermisporinN X Chin, H C Neu
The American Journal of Medicine|April 27, 1987
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteriaN X Chin, H C Neu
The Medical Clinics of North America|November 1, 1987
Chloramphenicol and tetracyclinesE L Francke, H C Neu
The Journal of Antimicrobial Chemotherapy|February 1, 1987
In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agentsH C Neu, N X Chin
Antimicrobial Agents and Chemotherapy|January 1, 1988
Tigemonam, an oral monobactamN X Chin, H C Neu
The Medical Clinics of North America|May 1, 1988
Parasitic infections: therapeutic considerationsW F Mandell, H C Neu
Pageof 51

Showing results (241-250 of 505) with videos related to

Sort By:
Pageof 51
Chemotherapy|January 1, 1986
In vitro activity of A-16686, a new glycopeptideH C Neu, N M Neu
Chest|November 1, 1993
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infectionsH C Neu, T W Chick
The Journal of Infectious Diseases|August 1, 1976
Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosisM F Parry, H C Neu
Antimicrobial Agents and Chemotherapy|August 1, 1992
In vitro activity of MC-352, a new 16-membered macrolideN X Chin, H C Neu
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
In vitro antimicrobial activity of the new antibiotic vermisporinN X Chin, H C Neu
The American Journal of Medicine|April 27, 1987
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteriaN X Chin, H C Neu
The Medical Clinics of North America|November 1, 1987
Chloramphenicol and tetracyclinesE L Francke, H C Neu
The Journal of Antimicrobial Chemotherapy|February 1, 1987
In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agentsH C Neu, N X Chin
Antimicrobial Agents and Chemotherapy|January 1, 1988
Tigemonam, an oral monobactamN X Chin, H C Neu
The Medical Clinics of North America|May 1, 1988
Parasitic infections: therapeutic considerationsW F Mandell, H C Neu
Pageof 51